Patient Reported Outcome (PRO) in Patients Receiving High and Moderate Emetogenic Chemotherapy (Ctx) - Results of a German Prospective Non-Interventional Study with Netupitant/Palonosetron Fixed Dose Combination (NEPA)

Autor: Karthaus, Meinolf, Klare, P ^*, Gazawi, N ^*, Zahn, MO ^*, Reimann, B ^*, Busch, S ^*, Schilling, Joerg ^*

Publikováno v: In Blood 29 November 2018 132 Supplement 1:4844-4844

Neratinib as Extended Adjuvant Treatment of HER2-Positive/HR-Positive Early Breast Cancer Patients in Germany, Austria, and Switzerland: Interim Results of the Prospective, Observational ELEANOR Study.

Autor: Harbeck N; Department of Obstetrics and Gynecology and CCC Munich, Breast Center, LMU University Hospital, Munich, Germany., Wrobel D; Sozialstiftung Bamberg Klinikum am Bruderwald, Bamberg, Germany., Zaiss M; Praxis fuer Interdisziplinaere Onkologie, Freiburg, Germany., Terhaag J; Rottal/Inn Clinic Eggenfelden, Eggenfelden, Germany., Guth D; Gyneco-Oncological Practice Dr. Guth, Plauen, Germany., Distelrath A; Praxisgemeinschaft Onkologie und Urologie, Wilhelmshaven, Germany., Zahn MO; MVZ Onkologische Kooperation Harz, Goslar, Germany., Wuerstlein R; Department of Obstetrics and Gynecology and CCC Munich, Breast Center, LMU University Hospital, Munich, Germany., Lorenz A; Gyneco-Oncological Practice Dr. Lorenz, Hildburghausen, Germany., Bartsch R; Division of Oncology, Department of Medicine I, Medical University of Vienna, Vienna, Austria., Breitenstein U; Divison of Oncology, Brust-Zentrum Zürich, Zurich, Switzerland., Schwitter M; Kantonsspital Graubünden, Chur, Switzerland., Balic M; Divison of Oncology, Department of Internal Medicine, Medical University Graz, Graz, Austria., Jackisch C; Department of Gynecology and Obstetrics, Klinikum Offenbach, Offenbach, Germany., Müller V; Department of Gynecology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Rinnerthaler G; Department of Internal Medicine III, Paracelsus Medical University Salzburg, Salzburg, Austria., Schmidt M; Department of Gynecology, University Hospital Mainz, Mainz, Germany., Zaman K; Breast Center, Lausanne University Hospital CHUV, Lausanne, Switzerland., Schinköthe T; CANKADO Service GmbH, Kirchheim, Germany., Resch A; Pierre Fabre Pharma GmbH, Freiburg, Germany., Valenti R; Pierre Fabre Medicament, Boulogne, France., Lüftner D; Immanuel Hospital Märkische Schweiz & Medical University of Brandenburg Theodor-Fontane, Brandenburg, Germany.

Publikováno v: Breast care (Basel, Switzerland) [Breast Care (Basel)] 2024 Feb; Vol. 19 (1), pp. 1-9. Date of Electronic Publication: 2023 Oct 05.

Treatment and outcome in metastatic lobular breast cancer in the prospective German research platform OPAL.

Autor: Thill M; Agaplesion Markus Krankenhaus, Frankfurt, Germany., Zahn MO; MVZ Onkologische Kooperation Harz, Goslar, Germany., Welt A; Universitätsklinikum Essen, Essen, Germany., Stickeler E; Universitätsklinikum Aachen, Aachen, Germany., Nusch A; Praxis für Hämatologie und internistische Onkologie, Ratingen, Germany., Fietz T; Schwerpunktpraxis für Hämatologie und internistische Onkologie, Singen, Germany., Rauh J; Gemeinschaftspraxis Innere Medizin, Witten, Germany., Wetzel N; iOMEDICO, Freiburg, Germany., Kruggel L; iOMEDICO, Freiburg, Germany., Jänicke M; iOMEDICO, Freiburg, Germany., Marschner N; Praxis für interdisziplinäre Onkologie und Hämatologie, Freiburg, Germany., Harbeck N; Brustzentrum, Frauenklinik LMU Klinikum, Munich, Germany., Wöckel A; Universitätsklinikum Würzburg, Würzburg, Germany., Decker T; Onkologie Ravensburg, Praxis für Hämatologie und Onkologie GbR, Ravensburg, Germany. thomas.decker@onkonet.eu.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2023 Apr; Vol. 198 (3), pp. 545-553. Date of Electronic Publication: 2023 Feb 18.

Real-World Evaluation of Quality of Life, Effectiveness, and Safety of Aflibercept Plus FOLFIRI in Patients with Metastatic Colorectal Cancer: The Prospective QoLiTrap Study.

Autor: Hofheinz RD; Department of Oncology, University Hospital Mannheim, Theodor-Kutzer-Ufer 1, 68167 Mannheim, Germany., Anchisi S; Department of Oncology, Valais Romand Hospital Center, Valais Hospital, Av. Grand-Champsec 86, 1951 Sion, Switzerland., Grünberger B; Department of Internal Medicine, Hematology and Oncology, Hospital Wiener Neustadt, Corvinusring 3-5, 2700 Wiener Neustadt, Austria., Derigs HG; Department of Internal Medicine 3, Hematology, Oncology, Palliative Medicine and Pneumology, Frankfurt Höchst Clinic, Gotenstrasse 6-8, 65929 Frankfurt am Main, Germany., Zahn MO; Department of Internal Medicine, Hematology and Oncology, MVZ Oncology Cooperation Harz, Kosliner Str. 14, 38642 Goslar, Germany., Geffriaud-Ricouard C; Sanofi, Global Medical Oncology, 54 Rue La Boetie, 75008 Paris, France., Gueldner M; Sanofi, Potsdamer Str. 8, 10785 Berlin, Germany., Windemuth-Kieselbach C; Department of Biometry, Alcedis, Winchesterstr 3, 35394 Giessen, Germany., Pederiva S; Center for Oncology and Hematology, Cantonal Hospital, Im Ergel, 5404 Baden, Switzerland., Bohanes P; Department of Oncology and Internal Medicine, Center for Chemotherapy, 1004 Lausanne, Switzerland., Scholten F; Department of Internal Medicine 3, Hematology, Oncology, Palliative Medicine and Pneumology, Frankfurt Höchst Clinic, Gotenstrasse 6-8, 65929 Frankfurt am Main, Germany., Piringer G; Department of Internal Medicine IV, Wels-Grieskirchen Hospital, Grieskirchner Str. 42, 4600 Wels, Austria.; Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria., Thaler J; Department of Internal Medicine IV, Wels-Grieskirchen Hospital, Grieskirchner Str. 42, 4600 Wels, Austria., von Moos R; Department of Oncology, Cantonal Hospital Graubuenden, Loestrasse 170, 7000 Chur, Switzerland.

Publikováno v: Cancers [Cancers (Basel)] 2022 Jul 20; Vol. 14 (14). Date of Electronic Publication: 2022 Jul 20.

Patient, nurse, and physician preferences: final results of the CONVENIENCE study evaluating pegfilgrastim prophylaxis via pre-filled syringe or on-body injector in cancer patients.

Autor: Metz M; OSP Göttingen, Göttingen, Germany., Semsek D; Praxis für interdisziplinäre Onkologie & Hämatologie, Freiburg im Breisgau, Germany., Rogmans G; ZAGO- Zentrum für ambulante gynäkologische Onkologie, Krefeld, Germany., Hutzschenreuter U; Hämatologisch-Onkologische Gemeinschaftspraxis, Nordhorn, Germany., Fietz T; Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie, Singen, Germany., Harde J; iOMEDICO, Freiburg im Breisgau, Germany., Zacharias S; iOMEDICO, Freiburg im Breisgau, Germany., Hielscher C; g.SUND Gynäkologie Kompetenzzentrum Stralsund, Stralsund, Germany., Lorenz A; Gynäkologische Onkologie, Frauenarztpraxis Dr. Lorenz, Hildburghausen, Germany., Zahn MO; Überörtliche Berufsausübungsgemeinschaft MVZ Onkologische Kooperation Harz, Goslar, Germany., Guth D; Gynäkologische Onkologie, Praxis Dr. med. Dagmar Guth, Plauen, Germany., Liebers S; KMG Klinikum Sömmerda, Sömmerda, Germany., Berghorn M; MVZ am Allgemeinen Krankenhaus Celle, Celle, Germany., Grebhardt S; iOMEDICO, Freiburg im Breisgau, Germany., Matillon CD; iOMEDICO, Freiburg im Breisgau, Germany., Egerer G; Universitätsklinikum Heidelberg, Klinik Für Hämatologie, Onkologie, Rheumatologie, Heidelberg, Germany., Potthoff K; iOMEDICO, Freiburg im Breisgau, Germany. manuscript@iomedico.com.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2021 Nov; Vol. 29 (11), pp. 6633-6643. Date of Electronic Publication: 2021 May 06.